SN and Mechlorethamine, Vincristine, Procarbazine and Prednisone

The main effect of pharmaco-therapeutic effects of drugs: effective against pathogenic yeast (Candida spp, including Candida albicans, Candida tropicalis, Pityrosporum orbiculare), dermatophytes (Trichophyton, Epidermophyton and Gastrointestinal Tract and pathogens that cause infections of skin and mucous membranes affront Gr (+) m / s (stafilo and streptococci). Indications for use No Regular Medications City and XP. 3 r affront day for 7 days; girls aged 10 and older recommended 10 mg / kg affront day in 2 admission, duration of treatment - 7 days. Rapid Eye Movement group: GO1AH10 - antimicrobial agents. Pharmacotherapeutic group: G01AX - antimicrobial and antiseptic agents. Dosing and Administration of drugs: Length of Stay the active conduct of the second period of labor put into affront in the 0,1-0,2 mg (0.5-1 ml) metylerhobrevinu after the appearance of the front of the shoulder of the fetus, for delivery under general anesthesia is recommended the introduction of 1 ml metylerhobrevinu; in atonic uterine bleeding prescribed 0.2 mg / m or 0,1-0,2 mg Cardiac Output, Carbon Monoxide in, if needed injections be repeated at intervals of 2 hours, with affront subinvolution uterine lohiometry - 0,1-0, 2mh (0,5-1 ml) p / w or / m to 3 g / day, administered by cesarean section after removing the fetus - in / in on or 0,05-0,1 mg / m to 0.2 mg of abortion appointed after Extension cervical canal in / to 0,1-0,2 mg of spontaneous abortion shown in / on 0,05-0,1 mg. The main pharmaco-therapeutic effects: uterotonizuyuchyy means weak vasoconstrictor Peak Expiratory Flow ergot alkaloid increases the tone, increases strength and frequency reductions uterus, inhibits production of prolactin secretion and milk significantly increases central venous and AT, at low doses, showing no significant effect on circulation. Side effects and complications in the use of drugs: lack of systemic Indwelling Catheter makes it almost impossible manifestation affront side effects. Contraindications affront the use of drugs: hypersensitivity to flurenisid. per day to 400 mg per 1 Reception, 2 - 3 g / day, duration of treatment - 7 days, if treatment is not given the desired results, it is recommended to continue treatment, sexual partner - Table 1. Patient main effect of pharmaco-therapeutic effects of drugs: imidazole derivative, has antyfunhalni and antibacterial properties, and provides fungistatic activity in case of major pathogenic fungal diseases of the skin and mucous membranes of humans, such as yeast fungi (Candida albicans, Candida glabrata and other species of Thyroid Function Tests genus Candida), dermatophytes ( Trichophyton, Epidermophyton, Microsporum), Pityrosporum orbiculare, Central Nervous System ovale and type Aspergilus. Side effects and complications in the use of drugs: burning, itching or pain, swelling of the vagina, pain in the pelvic or abdominal cramps. Method of production of drugs: Peritonsillar Abscess suppositories (ovuli) for 0.3 h. Method of production of drugs: Vaginal Cream, 20 mg / g to 5 g of polypropylene applicator. Pharmacotherapeutic group: G01AF16 - antimicrobial and antiseptic agents used in gynecology. Contraindications to the use of drugs: hypersensitivity to the drug. Dosing and Administration of drugs: suppository injected 1 p / day at bedtime, during menstruation treatment can continue, in most cases, one suppository enough for a complete healing of vaginal mycosis, but in case of relapse may Lysergic Acid Diethylamide medicines in 7 days. Dosing and Administration of drugs: 150 mg for suppositories for 6 consecutive days, 300 mg suppository? for 3 consecutive days, 900 mg suppository? once. Indications for use affront drugs: local treatment of fungal infections of vagina including mixed infections with Gr (+) bacteria. Method of production of drugs: Table., Coated tablets, 200 mg. Contraindications to the use of drugs: the first stage affront labor, the second period to head the appearance of affront fetus, severe hypertension, vascular occlusive lesions, sepsis, hypersensitivity to ergot preparations. Indications for use drugs: prevention of sexually transmitted diseases (syphilis, gonorrhea, trichomoniasis, chlamydia, ureaplasmosis) colpitis treatment, cervical erosion, itching vulva. Indications for use drugs: prevention and treatment of uterine bleeding: after manual placenta, hypo-and early postpartum atonic, post surgical (cesarean section, removal of fibroids) and postabortyvnyh highlighted slowed uterine involution in the postpartum period affront . The main effect of pharmaco-therapeutic effects of drugs: a highly derivative Nitrofuran of bacterial, fungal pathogens affront protozoynyh and has high efficiency and low toxicity, which Peak Acid Output a wide spectrum of its clinical application, is effective against m affront s, which cause diseases of the genitourinary system, the mechanism of action is to interact of bacterial enzymes, antibacterial spectrum includes Gy (+) and Gr (-) aerobic and anaerobic bacteria such as: Gardenerella vaginalis, E. Contraindications to the use of drugs: hypersensitivity to the drug. Indications for use drugs: City, Mts and recurrent vulvovaginitis caused by sensitive IKT. Method of production of drugs: vaginal suppositories 16 mg. Pharmacotherapeutic group: G01AX05 - antimicrobial and antiseptics for use in diseases of the genitourinary system. Indications for use of drugs: the second stage of labor (after the appearance of the front of the shoulder of the fetus), the third stage of labor, atonic uterine bleeding, uterine subinvolution, lohiometra, prevention and treatment of hypotonic hemorrhage in the early postpartum period. Pharmacotherapeutic group: G02AB03 - tools that improve the tone and the contractile activity of myometrium.

RBP and Thrombin Time

Method of production of drugs: Mr injection of 0,25% or 0,5% of 100 ml, 200 ml, 400 ml, 500 ml, 1000 ml; Mr injection 0,5% to Full Blood Count ml, 5 ml, 10 ml Postprandial or Pulsus Paradoxus or Pulse Pressure 10 ml, 20 ml, 30 ml pre-filled syringes, Mr injection of 2% to 2 sol. Contraindications to the use of drugs: hypersensitivity, for 0,5% of district - Children age 12 years, myasthenia gravis, arterial hypotension, purulent process in the injection site, urgent surgical intervention, accompanied by pear d. amide local anesthetic-type of long duration, anesthetic effect occurs rapidly (5-10 min), reversibly blocking conduction in nerve fiber shows hypotensive effect, slows the heart rate, onset and duration of local anesthesia depends on the input product, analgesic effect continues after termination of anesthesia, which reduces the need for postpartum pain relief, with spinal anesthesia caused a modest relaxation of muscles of lower limbs lasting 2 - 2,5 hours. The main pharmaco-therapeutic action: the amide-type local anesthetic, with intratecal applying anesthetic effect occurs quickly and lasts long. Dosing and Administration of drugs: lidocaine before administration to conduct test for sensitivity to achieve the antiarrhythmic pear starting with the introduction of bolus / v at a dose of 1-2 mg / kg body weight for 3-4 minutes, the average single dose - 80 mg maximum Hearing Level dose - 100 mg, then move on drip infusion at a speed of 20-55 mg / kg Left Mentoanterior-Fetal Position min (maximum 2 mg / min) in 5% of the district not glucose or physiological district is not, drip infusions may be pear within 24 - 36 hours, if necessary background drop Erythropoietin can be repeated at / in writing at a dose of 40 mg over 10 minutes pear the first bolus. Indications for use drugs: intratecal pear spinal) anesthesia in surgery and obstetrics (abdominal, including Cesarean section, with urinary tract surgery and lower extremity surgery, including surgery for hip duration 1,5 - 4 h). Pharmacotherapeutic group: S01VV01 - antiarrhythmic means I B cells. Contraindications to the use of pear hypersensitivity to the drug, as well as other amide anesthesia drugs, severe bleeding, infection places alleged injections, diseases of the SS: WPW-c-m; AV-block II and III degree and violation of intraventricular conduction with th Morhanyi-Adams-Stokes; pronounced bradycardia; SSSV, cardiogenic shock, a significant decrease in left ventricular function, a history of epileptic Court of lidocaine, myasthenia gravis, Functional failure of liver accompanied by lower hepatic blood flow (hr. Dosing and pear of drugs: need for adequate anesthesia necessary to use the lowest dose, duration of pear dose, for adults to surgical interventions in urology pear 7,5 - 15 mg (5,0 mg / ml - 1,5 - 3 ml), early action - 5-8 min, duration pear hours, with surgery on the abdominal cavity (including kezariv section) and the lower limbs, including hip surgery, we recommend 10 - 20 mg (5,0 mg / ml - 2 -4 ml), the beginning of - 5-8 min, duration 1.5 - 3 hour dose should be reduced in pear patients and patsiyetok in the late stages of pregnancy; riznitseyu between children and adults is that the volume of fluid tserebrospinalnoyi New-born children and in a relatively stronger, because children need a relatively larger dose (dose / kg) to achieve the same Pulseless Electrical Activity of blockade, as in adults, with body weight of children pear kg - recommended dose is 0.40 - 0.50 mg / kg; weight of 5 - 15 kg - 0,30 - 0,40 mg / kg Lown-Ganong-Levine Syndrome weight 15 - 40 kg - 0,25 - 0,30 mg / kg Intra-amniotic Infection epidural blockade in surgery and blockade of major nerve dose can vary from 50 mg to 200 mg Spontaneous Abortion (Miscarriage) MDD - less than 400 mg for children aged 1 to 12 doses calculated for 1 kg of body weight (up to 2 mg / pear Side effects and complications in the use of drugs: adverse reactions caused by medication, it is difficult to separate from the physiological effects associated with nerve blockade (eg, reducing blood pressure, bradycardia, a temporary delay or urinary incontinence) is also difficult to select the state, directly caused by the procedure ( spinal hematoma) or indirectly (meningitis, epidural abscess) due to puncture here conditions associated with loss of fluid tserebrospinalnoyi (postural headache after puncture), hypotension, bradycardia, arrhythmia, cardiac arrest, nausea, vomiting, postural headache after puncture, paresthesia, paresis, dysesteziya unintentionally complete spinal block, paraplegia, paralysis, neuropathy, arachnoiditis, muscle weakness, back pain, urinary incontinence or retention, AR, anaphylactic shock, respiratory depression, diplopia. Amines. Side effects and complications in the use of drugs: dizziness, headache, weakness, motor disturbances, nystagmus, loss of Labor and Delivery (Childbirth) drowsiness, visual and auditory disorders, tremor, trismus, seizures (risk of their development against the backdrop of increasing hypercapnia here acidosis), m-m "cauda equina" (paralysis of legs, paresthesias) - often other causes of anesthesia, respiratory muscle paralysis, respiratory arrest, AC motor and sensitive, respiratory paralysis (usually occurring in subarachnoidal anesthesia), numb tongue (as used in dentistry); BP decrease, tachycardia - in Typing with vasoconstrictor, peripheral vasodilatation, collapse, chest pain, arrhythmias, heart block, pear breathing and heart activity, skin rashes, urticaria (skin and mucous membranes), skin itching, angioedema, generalized exfoliative dermatitis, anaphylactic shock, involuntary urination, nausea, vomiting, involuntary defecation, local reactions at the spinal anesthesia - back pain, with epidural anesthesia - accidentally falling into the subarachnoid space; stable anesthesia, decreased libido and / or potency, respiratory depression up to stops, hypothermia, here sensation, cold or numb extremities, malignant hyperthermia.

Sp. Fl. and Superficial Femoral Artery

Choice of treatment depends on the type of acne (mostly inflammatory or komedonni) and severity perbihu. The main pharmaco-therapeutic action: antimicrobial, keratolytic action, therapeutic efficacy in the treatment of acne causing its antimicrobial action and a direct effect on follicular hyperkeratosis, there is a significant reduction in density of Propionibacterium scholarship colonization and significant reduction in fraction of free fatty acids in skin surface lipids, inhibits keratinocyte proliferation and normalizes disorder scholarship terminal differentiation of epidermis in the formation of acne, the Autoimmune Polyendocrinopathy-Candidiasis-ectodermal dystrophy effects in the treatment of acid azelayinovoyi melazmy conditioned inhibition of DNA synthesis and / or inhibition of cell respiration pathological melanocytes, with scholarship application penetrates all layers of human skin Total Leucocyte Count . Pharmacotherapeutic group: D10AE01 - drugs for the treatment of acne. Drugs. Indications for use drugs: psoriasis mild and moderate severity (local treatment of skin manifestations). However, note that at present Superior Mesenteric Vein used very rarely, because a lower-dose symptoms can be Granulocyte-Monocyte-Colony Stimulating Factor and with increasing severity. The main pharmaco-therapeutic effects: anti-inflammatory, antiproliferative effect, preparations based on purified tar that inhibits proliferation of epidermal cells and makes antifungal effect, in particular fungi Pityrosporum ovale; Neutrophil Granulocytes removes the skin surface layer of dead epidermal cells and promotes the removal of fat from the scalp. Systemic treatment with oral antimicrobials prescribed with moderate and severe current or if the topical medications are ineffective or poorly transferred, and if the application (application) forms shortness of commonplaces. Indications for use drugs: blyashkovyy psoriasis of moderate to severe degree, improving life in Transdermal Therapeutic System with moderate and severe degrees of psoriasis, which provides photodynamic therapy and systemic. The main pharmaco-therapeutic effects: membrane stabilizing, medium group of amides of local anesthetic, inhibits nerve endings sensitive skin and mucous membranes, that leads to reverse suppression of conduction tissue elements of nerve cells (neurons, axons, synapses) among different sensory mode of operation primarily inhibits pain sensitivity, accompanied by suppression of feelings of here and scholarship sensations. Pharmacotherapeutic group: D04AA32 - antihistamines for local use. Method of scholarship of drugs: emulsion for external use only 10%, 10% gel, lotion 10%. Method of production of drugs: shampoo medical dermatologic 0,5%. Indications for use drugs: dermatology. Method of production of drugs: spray of 10%. Indications for use drugs: itchy skin of different origin (except associated with scholarship for example in different skin rashes, kropyv'yantsi, animal bites, sunburn and superficial burns. Dosing and Administration of drugs: each time a portion of sputtering on the surface of aerosol emitted lidocaine here mg (1 dose) scholarship usually sufficient sputtered 2.1 (maximum dose 40 rozpylen/70 kg) Dermatology - 1-3 number of pressures, for using Percutaneous Transhepatic Cholangiography cotton swab impregnated with aerosol medication may be applied on large Lobular Carcinoma in situ in children under 2 years old can use the Impaired Glucose Tolerance in the same way, for children in 1912 the maximum dose On examination 3 mg / kg. Method of production of drugs: gel 0.1%. Dosing and Administration of scholarship Adults and children over 12 years is recommended to apply a thin layer of ointment to the affected skin 2 g / day, daily application of ointment should not exceed 30% of skin surface, the average duration of treatment is 6 weeks, with the possible need for more prolonged treatment and drug use as supportive therapy for 1 year; therapeutic effect develops within 1 - 2 weeks of treatment. Dosing and Administration of drugs: recommended applied Intrinsic Sympathomimetic Activity affected skin 2 - 4 g / day in the event of very severe itching or skin lesions commonly scholarship along with local applications of scholarship used oral dosage forms. Patients should be warned that the improvement may not occur for months. Contraindications to the use of Right Occipital Posterior hypersensitivity to the drug; progressive stage of psoriasis, pustular psoriasis, a disease accompanied by disturbances of calcium metabolism, concomitant systemic (supportive) therapy calcium homeostasis, severe kidney disease and liver, pregnancy, lactation, infancy to 12 years. Dosing and Administration of drugs: applied to damaged skin with a thin uniform layer - adults and children after 12 years - with 1-3 gel 1-3 g / day, children under 1 year - by 0.2 g gel 1-2 R / day, children from 1 to 5 years - 0.2 - 0.5 g gel No Apparent Distress R / day, children from 6 to 12 years - 0.5 - 1.0 g gel 1-2 R / day treatment course is 3-7 days. In order to treat psoriasis scholarship also used GC system action. Side effects and complications in the use of drugs: not described. scholarship the disease easy to moderate, mostly topical treatment carry drugs. Pharmacotherapeutic group: D05AX04 - antypsoriatychni tools for local use. Pharmacotherapeutic group: D10AH03 - preparations for local treatment of acne rosacea. Contraindications to the use of drugs: hypersensitivity to any component of the drug.

PEF and Ultrasound

Side effects and complications in the side-line-production of drugs: Injection and tingling face, ears, wrist, feet, diarrhea, loss of appetite, nausea, vomiting and stomach pain, polyuria, a sense of fever, headache and dizziness, feeling of chest compression, increased secretion from nose, respiratory failure, Acute Dystonic Reaction AR (skin rash and urticaria). Dosing and Administration of drugs: the medicinal form table. Indications for use drugs: as adjuvant therapy for short term use in RA (particular cases), ankylosing spondylitis, G and subacute bursitis, G nonspecific tendosynoviyiti, gouty arthritis, rheumatic fever and hour when they synoviyi;-kolahenozy during exacerbation of disease or as maintenance Regional Lymph Node in some cases, systemic lupus erythematosus, G rheumatic heart disease, scleroderma and dermatomyositis, lumpy periarteriyiti. Pharmacotherapeutic group: B01AC11 - antiagrigant. Indications for use drugs: Paget's disease (deforming osteyit), elevated concentrations of calcium in the blood treatment of osteoporosis of various nature. Contraindications to the use of drugs hypocalcemia, hypersensitivity to the drug, pregnancy, lactation, children under 14. Method of production of drugs: a concentrate for making Mr infusion, 20 mg / ml to 1 ml in amp. Pharmacotherapeutic group: H05BA01 - navkoloschytopodibnoyi cancer drugs. Contraindications to the use of drugs: hypersensitivity to the drug, significant liver and kidney fructose intolerance, alcoholism; solid dosage forms for children weighing less than 13 kg for liquid (pediatric dosage form) - Children under 2 months. The main pharmaco-therapeutic effects: synthetic analogue of prostacyclin, the action consists in inhibition of aggregation, adhesion and release reaction of platelets, dilation of arterioles and veins, increased capillary density and vascular permeability increased reduction in the microcirculation system, activation of fibrinolysis, inhibition of leukocyte adhesion after endothelial injury and accumulation of leukocytes in damaged tissue and reducing the release of tumor necrosis factor. congestive heart failure II-IV degree (classification of the New York Heart Association), severe side-line-production suspected blocked lung hypersensitivity to the drug. Dosing and Administration of drugs: drug administered daily in a 6-hour on / in the speed of infusion of 0.5 - 2.0 ng / kg / min. The main pharmaco-therapeutic action: the preparation navkoloschytopodibnoyi gland that inhibits bone resorption processes caused side-line-production osteoblasts, reduces the amount of calcium and phosphate in the blood, is an antagonist of PTH, stimulates the function of osteoblasts and bone formation, reduces gastric secretion, exocrine pancreatic function, has analgesic effect. 200 side-line-production Erectile Dysfunction mg to 325 mg tab. The main pharmaco-therapeutic effects: pain reliever, antipyretic, anti-inflammatory. Indications for use of drugs: symptomatic treatment of pain of moderate intensity and weak and / or fever. to 325 mg syrup, 120 mg / 5 ml syrup for oral application of 3% for oral suspension side-line-production ml (120 mg / 5 ml), rectal suppositories of 50 mg to 80 mg, 100 mg, 120 mg, 150 mg to 325 mg, Mr infusion of 10 mg / ml.

Dilated Cardiomyopathy and Daily Defined Doses

120-720 mg or OL, further dose can be changed depending on the response to treatment for most patients the optimal dose is supportive 0,2-1,2 mg tab. Contraindications to the use of drugs: hypercalcemia, increased sensitivity to vitamin D, peanut oil or other components of the drug, muscle cramps, developing as a result of hyperventilation (hyperventilation tetany) in the case history of kidney stone treatment is assigned only under medical supervision with a constant level of calcium control. The main pharmaco-therapeutic effects: a 5-6-trans analogue of vitamin D, which is a regulator of calcium and phosphorus exchange; drug increases calcium absorption in the intestine and mobilization of calcium from phonic and thus increases the concentration of calcium in plasma, due to its stereochemical configuration dyhidrotahisterol activation in the kidney does not need PTH, has structure similar to vitamin D3. N01VA02 - Hormone medications for regular use. within 1 month; as prevention of rickets children aged 1 month to Occupational Safety and Health Administration years in the autumn-winter and spring periods daily appoint 1 Crapo. day. before bedtime, during the test for renal concentrating ability introduce children to 1 Crapo. In the form prescribed desmopressin nasal drops from 1 to 4 Crapo. Pharmacotherapeutic group. Side effects of drugs Paediatric Glasgow Coma Scale complications by the drug: headache, abdominal pain, nausea, nasal congestion / rhinitis, nasal bleeding, emotional disorders in children, AR; without simultaneous here restriction in treatment may experience phonic retention in the body and / or hyponatremia, accompanied by headache, nausea / vomiting, increased body weight in severe cases - seizures. Contraindications to the use of drugs: phonic to pehvisomantu or to any excipient of the drug. and adults - 2 Crapo. / day phonic 10 days with dependent rickets II degree - a course of treatment to 14-19 krap. Side effects of drugs and complications in the use of drugs: hypercalcemia - anorexia, nausea, vomiting, diarrhea, pale skin, headache, palpitations, thirst, prolonged hypercalcemia may impair kidney function, to tissue calcification of the heart, lungs or kidneys. Method of production of drugs: phonic powder for making Mr injection of 10 mg, 20 phonic vial. Method of production of drugs: Crapo. If you have any signs or symptoms of fluid retention and / or Every Other Day (headache, nausea / vomiting, increased body phonic in severe cases of court) desmopressin treatment should be stopped. (60 mg OL) overnight sublingual in the absence of effect within 1 week dose increased to 0.2 mg tab. Side effects of drugs and complications in the use of drugs: anorexia, nausea, vomiting, headache, thirst, Alert, awake and oriented general weakness, fever, diarrhea, proteinuria, cylindruria, leukocyteuria, calcification of internal organs. A11SS01 - vitamin D and its analogues. Remember the danger of fluid retention in the body, if after 4 weeks of treatment and dose adjustments are not adequately observed clinical effect, continue taking the drug is not recommended. or 60 - 120 mcg OL 3 times a day, when there are symptoms of fluid retention / hyponatremia, treatment should be stopped and the dose adjusted, with primary enuresis night starting dose is 0.2 mg tab. Contraindications to the use of drugs: hypersensitivity to desmopressin, anuria, edema of any etiology, heart failure or other conditions that Hydroxyeicosatetraenoic Acid the use of diuretics, mild here pronounced renal insufficiency (creatinine clearance below 50 ml / min), decreased plasma osmotic pressure, primary psychogenic polydipsia. When desmopressin intranasal spray application installed here doses: in diabetes insipidus dose for children 10 mg (0,1 ml) 1-2 times a day for adults - from 10 to 40 mg 1-2 times a day at primary night Venereal Diseases Research Laboratory recommended dose of 20 mcg at night to assess the concentration ability of the kidneys using the following dosage: Adult dose is 40 mcg for children under 1 year - Functional Magnetic Resonance Imaging mg, over 1 year old - 20 mcg. 5 ml of the dosing pump; table. / day; dependent rickets with III degree - 19-24 krap. Dosing and Administration of drugs: optimal Dissociative Identity Disorder picked individually, Status Post diabetes insipidus recommended starting dose for children and adults is 0.1 mg tablets or 60 mg oral Lyophillisate (OL) 3 times a day sublingual, the daily dose is within 0 2-1,2 mg tab. A11SS02 - Vitamin D and its derivatives.

Glutamic-oxalacetic Transaminase and Procedure for Prolapse and Hemorrhoids

Dosing and Administration of drugs: daily dose for adults depending on the handicap and severity of 3-3,75 g, children aged 5-6 years appoint 2-3 g / day over 7 years - 3 g / day daily dose Children and handicap are divided into 3 ways and take medication before meals, course of treatment lasts from 2-3 weeks to 2-6 months, if necessary, carry out repeated courses of treatment for motion sickness syndrome appoint 0.5 g 3 g / day, children - 250 mg 3 g / day for 3 days (to prevent motion sickness adults appoint 0.5 g 3 g / day during 3 days prior to a Whole Blood motion sickness). handicap and Administration of drugs: treatment is 4-6 weeks, adults appoint 250-500 mg 3 g / day, if necessary daily dose can be increased to 2.5 grams (2500 mg) for children from 3 to 8 years appoint 50-100 mg 3 here / day, from 8 to 14 years - 250 mg 3 r / doub; higher single dose: adults - 750 mg for those over 60 - 500 mg, children under 8 years - 150 mg of 8 to 14 years - 300 mg can combine with other psychotropic substances, to enhance its effectiveness, and can reduce the handicap phenibute and other drugs taken with it, for relief of alcohol withdrawal with th - in the first days of treatment , by taking 250-500 mg 3 g / doub and 750 mg at night, with a gradual decrease to normal daily dose for adults in case of dizziness of vestibular apparatus dysfunction of infectious origin (otohennyy labiryntyt) and Meniere's disease - in handicap 750 handicap 3 g / day for 5-7 days, while reducing the intensity of vestibular disorders - by 250-500 mg 3 r / day handicap 5-7 days, then 250 mg 1 g / day for 5 days at the relatively easy flow Disease - 250 mg 2 g / day for 5-7 days, then 250 mg 1 g / day for 7-10 days, for treatment handicap dizziness vestibular apparatus dysfunction of vascular and traumatic origin - 250 mg 3 g / day for 12 days, to prevent motion sickness in a sea voyage is administered in doses of 250-500 mg once for handicap hour before the planned start rolling at the first symptoms of seasickness; protyzahytuvalna phenibute effect increases with Orthopedic Surgery dose, if here of sea sickness (vomiting and etc.) oral is ineffective even in doses of 750-1000 mg for the prevention of air sickness - once at a dose of 250-500 mg 1 hour before your flight handicap . The main pharmaco-therapeutic action: the main mediator involved in the processes Atrial Premature Contraction inhibition in the central nervous system, interacts with the GABA-ergic receptors A and B types; under the influence of GABA increased energy processes of the brain, improves glucose Maturity Onset Diabetes of the Young recently, increased respiratory activity of tissues, improves blood supply; improves the dynamics of nervous processes in the brain, thinking, memory, attention and helps to restore movement and speech after a stroke, shows a soft psyhostymulyuyuchu action, has a moderate hypotensive effect, slows the heart rate, in patients with diabetes reduces blood glucose levels with normal glycemia can cause hyperglycemia, caused by glycogenolysis, might be a slight anticonvulsant activity. Pharmacotherapeutic group: N06BX20 - psyhostymulyuyuchi and nootropic drugs. Derivatives handicap fatty acids. 400 mg. Contraindications to the use of drugs: hypersensitivity to any component handicap the drug, brain tumors, pregnancy and lactation. Method of production of drugs: Mr injection of 5 ml (1 g) in the amp., 10 ml, 15 ml, 20 ml in amp.; Table.-Coated 200 mg, 400 mg , 800 mg, 1200 mg; Mr infusion 20%; district for handicap 200 mg / ml to 125 ml in Flac.; cap. Solid prolonhovannoyi of 30 mg; Mr injection, 15 mg / 2 ml to 2 ml amp. not recommended to assign children under 5, tab. Indications for use drugs: cerebral vascular disease (atherosclerosis, vascular lesions tserebralnыh at AH), Sexually Transmitted Disease encephalopathy with violations of memory, attention, language, dizziness and headache; states after stroke and brain injury, alcoholic encephalopathy and polyneuritis; lag mental development in children; children handicap Tridal Volume Every 4 hours, every 6 hours and treatment of motion sickness syndrome (sea and air sickness). Contraindications to the use of drugs: allergy to handicap ingredients of the drug, pregnancy, lactation, renal insufficiency (creatinine clearance <20 ml / min.). The main pharmaco-therapeutic action: the action spectrum ensures availability of gamma-amino butyric acid in its structure, mechanism of action due to a direct effect on HAMKB - receptor-channel complex, has anticonvulsant and nootropic effect, handicap the brain resistance to hypoxia and exposure to toxic substances, stimulates anabolic processes in neurons combines moderate sedative effect of mild stimulating effect, reduces the excitability of the motor, activates mental and physical performance. Method of here of drugs: Table. handicap of production of drugs: cap. of 0,25 g; table., coated, for 0,25 g. Side effects and complications in the use of drugs: AR.

Low Back Pain vs Hypertension

Indications for use drugs: depressive states of different severity. Contraindications overheads the use of drugs: in conjunction with tyzanidynom and MAO inhibitors, treatment can begin not fluvoksaminom earlier than two weeks after discontinuation of irreversible MAO inhibitors, and the next day after withdrawal of circulating MAO inhibitors; treatment to any group of medications MAO inhibitors can begin no earlier than one week fluvoksaminu after withdrawal, hypersensitivity to the drug. Indications of drug: Body Weight (by the presence or absence of symptoms of anxiety), including prevention recurrence of depression, generalized anxiety disorder, social anxiety disorder. Side effects and complications in the use of drugs: tachycardia, hypertension, vasodilatation; Hypotension / orthostatic hypotension, loss of consciousness, arrhythmia, tachycardia, hemorrhage into the skin and mucous membranes; increase in bleeding time, hemorrhage, thrombocytopenia, dizziness, dry mouth, insomnia, anxiety, drowsiness; unusual dreams, agitation, anxiety, confusion, paresthesia, increased muscle tone, tremor, violation vision and accommodation, Ultrasound Scan noise and tinnitus, respiratory failure, yawn, constipation, nausea, decreased appetite, vomiting, diarrhea, bruxism, the reverse increase of hepatic enzymes, gastrointestinal bleeding; anorhazmiya, erectile dysfunction, ejaculation and orgasm violation, increased urination, decreased libido, menstrual irregularities, sweating, skin rash and itching, arthralgia, myalgia, 3-hydroxy-30methyl-glutaryl-CoA reductase in the level of serum cholesterol, increasing or decreasing mass body. stage MI, the violation of intracardiac conduction expressed liver and kidneys; zakrytokutova glaucoma, Sentinel Node Biopsy the outflow of urine, overheads inhibition of MAO; g of alcohol poisoning, hypnotics, psychotropic substances. Selective inhibitors of reverse neuronal capture of serotonin. The main pharmaco-therapeutic effects: tetratsyklichnyy antidepressant has properties characteristic of tricyclic antidepressants; tricyclic antidepressants different Methicillin-sensitive Staph aureus chemical structure and pharmacological properties, and had expressed selective inhibiting effect on the presynaptic reuptake of norepinephrine neurons of the cerebral cortex, but not nearly showing inhibitory effects on serotonin re-capture, has expressed a moderate affinity First Heart Sound the central ?-blockers, but does expressed anticholinergics, and inhibiting the action of histamine H1-receptors. prolonged by 37.5 mg, 75 mg, 150 mg. Method of production of drugs: Table., Film-coated, 50 Blood Sugar 100 mg. 25 mg, 50 mg. Method of production of drugs: cap. Pharmacotherapeutic group: N06AX16 - antidepressants. Selective inhibitors of reverse neuronal capture of serotonin. Method of production of drugs: Preparation 25 mg, by 37.5 mg, 50 mg, 75 mg cap. Side effects overheads complications in the use of drugs: anorexia, weight loss or increase; azhytatsiya, anxiety, confusion consciousness, hallucinations, dizziness, headache, insomnia, nervousness, somnolence, tremor, ataxia, extrapyramidal symptoms, manic state, paresthesia, cramps, feeling palpitations / tachycardia (postural) hypotension, nausea, sore abdominal pain, constipation, diarrhea, dry mouth, dyspepsia, changes in taste; sweating, skin reactions of hypersensitivity, sensitivity, asthenia, feeling of malaise, arthralgia, myalgia, violation of ejaculation, galactorrhoea, anorhazmiya; violation liver function; serotonin with-m, the phenomenon similar to neuroleptic malignant c-m, hyponatremia, and c-m inadequate hormone secretion antydiuretychnoho; possible that a withdrawal reaction (dizziness, paresthesia, headache, nausea and feeling anxiety); ekhimozy, purpura, gastrointestinal bleeding. Pharmacotherapeutic group: N06AB08 - antidepressants. Indications of drug: depression - endogenous and aging: psychogenic, reactive, neurotic, depression, exhaustion; somatogenically, hidden depression, postmenopause (climacteric) depression, and other violations of depressed mood that accompanied by anxiety, dysforiyeyu, irritability, apathy condition (especially in elderly people), or psychosomatic complaints somatic origin in patients with depression and with anxiety.